ID

39170

Descripción

Chinese Medicine on Deferring Dialysis Initiation; ODM derived from: https://clinicaltrials.gov/show/NCT02194946

Link

https://clinicaltrials.gov/show/NCT02194946

Palabras clave

  1. 7/12/19 7/12/19 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

7 de diciembre de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility End-Stage Renal Disease NCT02194946

Eligibility End-Stage Renal Disease NCT02194946

Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
aged 18-75 years;
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
egfr <15 ml/min per 1.73 m2;
Descripción

Estimated Glomerular Filtration Rate

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3811844
non-diabetic ckd, which should be identified by biopsy or patients' medical histories.
Descripción

Chronic Kidney Disease Biopsy | Chronic Kidney Disease Medical History | Diabetes Mellitus Absent

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1561643
UMLS CUI [1,2]
C0005558
UMLS CUI [2,1]
C1561643
UMLS CUI [2,2]
C0262926
UMLS CUI [3,1]
C0011849
UMLS CUI [3,2]
C0332197
yellow race.
Descripción

Racial group Yellow

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0034510
UMLS CUI [1,2]
C0221205
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
clinical indications of dialysis still occur after conservative kidney management for 1 week, which will be ruled out as hemoglobin < 70g/l; or serum potassium> 5.5mmol/l; or co2cp <13mmol/l; or epi-gfr≤5ml/min/1.73m2 ;
Descripción

Indication Dialysis | Status post Conservative Treatment Kidney | Hemoglobin measurement | Serum potassium measurement | Carbon dioxide combining power measurement | Glomerular Filtration Rate CKD-EPI

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C3146298
UMLS CUI [1,2]
C0011946
UMLS CUI [2,1]
C0231290
UMLS CUI [2,2]
C0459914
UMLS CUI [2,3]
C0022646
UMLS CUI [3]
C0518015
UMLS CUI [4]
C0302353
UMLS CUI [5]
C0546630
UMLS CUI [6,1]
C0017654
UMLS CUI [6,2]
C2964649
pregnant or lactating.
Descripción

Pregnancy | Breast Feeding

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
critical status, such as alimentary tract hemorrhage or decompensated cirrhosis;
Descripción

Patient status determination, critical | Gastrointestinal Hemorrhage | Decompensated cirrhosis of liver

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0184770
UMLS CUI [2]
C0017181
UMLS CUI [3]
C1619727
history of malignancy other than a successfully and completely treated carcinoma;
Descripción

Malignant Neoplasms | Exception Carcinoma Treated Completely

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0007097
UMLS CUI [2,3]
C1522326
UMLS CUI [2,4]
C0205197
any condition (mental or physical) that would interfere with the patient's ability to comply with the study protocol;
Descripción

Mental condition Interferes with Protocol Compliance | Individual Physical Condition Interferes with Protocol Compliance

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C3840291
UMLS CUI [1,2]
C0521102
UMLS CUI [1,3]
C0525058
UMLS CUI [2,1]
C3714565
UMLS CUI [2,2]
C0521102
UMLS CUI [2,3]
C0525058
concurrent or current treatment with glucocorticoid or immunosuppressant agents in last 3 months;
Descripción

Glucocorticoids | Immunosuppressive Agents

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0017710
UMLS CUI [2]
C0021081
participation in any other clinical trial;
Descripción

Study Subject Participation Status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2348568
known or suspected allergy to certain agents involved;
Descripción

Hypersensitivity Investigational New Drugs | Hypersensitivity Suspected Investigational New Drugs

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0013230
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0750491
UMLS CUI [2,3]
C0013230

Similar models

Eligibility End-Stage Renal Disease NCT02194946

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
aged 18-75 years;
boolean
C0001779 (UMLS CUI [1])
Estimated Glomerular Filtration Rate
Item
egfr <15 ml/min per 1.73 m2;
boolean
C3811844 (UMLS CUI [1])
Chronic Kidney Disease Biopsy | Chronic Kidney Disease Medical History | Diabetes Mellitus Absent
Item
non-diabetic ckd, which should be identified by biopsy or patients' medical histories.
boolean
C1561643 (UMLS CUI [1,1])
C0005558 (UMLS CUI [1,2])
C1561643 (UMLS CUI [2,1])
C0262926 (UMLS CUI [2,2])
C0011849 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
Racial group Yellow
Item
yellow race.
boolean
C0034510 (UMLS CUI [1,1])
C0221205 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
Indication Dialysis | Status post Conservative Treatment Kidney | Hemoglobin measurement | Serum potassium measurement | Carbon dioxide combining power measurement | Glomerular Filtration Rate CKD-EPI
Item
clinical indications of dialysis still occur after conservative kidney management for 1 week, which will be ruled out as hemoglobin < 70g/l; or serum potassium> 5.5mmol/l; or co2cp <13mmol/l; or epi-gfr≤5ml/min/1.73m2 ;
boolean
C3146298 (UMLS CUI [1,1])
C0011946 (UMLS CUI [1,2])
C0231290 (UMLS CUI [2,1])
C0459914 (UMLS CUI [2,2])
C0022646 (UMLS CUI [2,3])
C0518015 (UMLS CUI [3])
C0302353 (UMLS CUI [4])
C0546630 (UMLS CUI [5])
C0017654 (UMLS CUI [6,1])
C2964649 (UMLS CUI [6,2])
Pregnancy | Breast Feeding
Item
pregnant or lactating.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Patient status determination, critical | Gastrointestinal Hemorrhage | Decompensated cirrhosis of liver
Item
critical status, such as alimentary tract hemorrhage or decompensated cirrhosis;
boolean
C0184770 (UMLS CUI [1])
C0017181 (UMLS CUI [2])
C1619727 (UMLS CUI [3])
Malignant Neoplasms | Exception Carcinoma Treated Completely
Item
history of malignancy other than a successfully and completely treated carcinoma;
boolean
C0006826 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0007097 (UMLS CUI [2,2])
C1522326 (UMLS CUI [2,3])
C0205197 (UMLS CUI [2,4])
Mental condition Interferes with Protocol Compliance | Individual Physical Condition Interferes with Protocol Compliance
Item
any condition (mental or physical) that would interfere with the patient's ability to comply with the study protocol;
boolean
C3840291 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C0525058 (UMLS CUI [1,3])
C3714565 (UMLS CUI [2,1])
C0521102 (UMLS CUI [2,2])
C0525058 (UMLS CUI [2,3])
Glucocorticoids | Immunosuppressive Agents
Item
concurrent or current treatment with glucocorticoid or immunosuppressant agents in last 3 months;
boolean
C0017710 (UMLS CUI [1])
C0021081 (UMLS CUI [2])
Study Subject Participation Status
Item
participation in any other clinical trial;
boolean
C2348568 (UMLS CUI [1])
Hypersensitivity Investigational New Drugs | Hypersensitivity Suspected Investigational New Drugs
Item
known or suspected allergy to certain agents involved;
boolean
C0020517 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0750491 (UMLS CUI [2,2])
C0013230 (UMLS CUI [2,3])

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial